Hexachlorophene
As of the edition of 20 October 2026, Hexachlorophene is a small molecule: marketed, first approved in 1982 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Phisohex
- First approved
- 1 January 1982 (US)
- Approvals on record
- 19 in 1 region
- Holder of the most recent approval
- Xttrium; 12 holders in all
- Withdrawn from market
- 1 January 1988 (in some regions)
- Registered trials
- 2, 0 stopped early
- Disease areas
- Infections; Immune system; Skin and connective tissue; Urinary and reproductive
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 2 | 0 | 0 |
| All trials | 2 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Becton Dickinson | Acquired holder | 2003 to now |
| Dial | Acquired holder | 2003 to now |
| Merck & Co. | Acquired holder | 2003 to now |
| Pfizer | Acquired holder and Later holder | 2003 to now |
| Professional Disposables | Acquired holder | 2003 to now |
| Vestal | Acquired holder | 2003 to now |
| 3M | Later holder | |
| Arbrook | Applicant | |
| Bayer | Later holder | |
| Huntington | Later holder | |
| Sanofi | Later holder | |
| Xttrium | Later holder |